Staphylococcus aureus in chronic and recurrent infections

Ninety-four Staphylococcus aureus strains isolated from chronic and recurrent skin and respiratory tract infections were investigated for several virulence factor expressions. Production of protein A was noticed in all of the tested strains in amounts from less than 0.1 to more than 2.5 ng per 10(6)...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Folia microbiologica 1995-01, Vol.40 (6), p.655-658
Hauptverfasser: SLOBODNIKOVA, L, KOTULOVA, D, ZAHRADNIKOVA, I
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Ninety-four Staphylococcus aureus strains isolated from chronic and recurrent skin and respiratory tract infections were investigated for several virulence factor expressions. Production of protein A was noticed in all of the tested strains in amounts from less than 0.1 to more than 2.5 ng per 10(6) bacterial cells. The percentage of the extracellularly produced protein A was found to lie between 4.5 and 27.8%. Two strains (both from the respiratory tract) produced more than 50% of protein A in the extracellular form and one strain did not produce any detectable amount of the extracellular protein A; 99% of the tested strains produced the clumping factor, 96% staphylocoagulase, 79% staphylokinase and 90% gelatinolytic activity; 79% produced alpha-toxin exclusively or in combination with delta- or beta-toxin; 8% of strains produced beta-toxin. There were differences in beta-toxin production between strains from the respiratory tract (5%) and skin infections (25%). delta-Toxin was produced by 53% of the strains. In each of the tested strains a complex of virulence factors was detected. The importance of inactivated extracellular products (especially alpha- and delta-toxin and in the case of skin infections also beta-toxin) as components of staphylococcal whole-cell vaccine was suggested.
ISSN:0015-5632
1874-9356
DOI:10.1007/BF02818525